Study linked three DNA regions to bladder cancer risk
Three DNA regions were linked to bladder cancer risk in a study published in Nature Genetics on 24 October 2010. Researchers scanned 591,637 single-letter DNA variations in 3,532 people with bladder cancer and 5,120 controls of European descent from five studies. Controls were people without bladder cancer used for comparison. The team followed up the findings in 8,382 cases and 48,275 controls from 16 studies. The combined analysis identified new associations in chromosome regions 22q13.1, 19q12 and 2q37.1, and confirmed several associations reported in earlier research.
The researchers used a genome-wide association study, which searches across DNA for variations linked to a disease. Their study combined an initial scan with follow-up research to check the findings in further groups of people.
Of the three newly identified regions, one lay outside a gene. The DNA variant rs1014971 mapped to this region, 22q13.1. Variant rs8102137 mapped to CCNE1 in region 19q12, while rs11892031 mapped to the UGT1A cluster, a group of genes in region 2q37.1.
The statistical evidence differed between the regions. The researchers reported P values of 8 × 10⁻¹² for rs1014971, 2 × 10⁻¹¹ for rs8102137 and 1 × 10⁻⁷ for rs11892031. These values describe the statistical evidence for an association. They do not say how much a person's risk of bladder cancer changes with a particular variant.
The combined analysis also confirmed four previously identified genome-wide associations in chromosome regions 3q28, 4p16.3, 8q24.21 and 8q24.3. Alongside those findings, it validated two previously proposed associations with bladder cancer risk. One involved deletion of the GSTM1 gene, with a P value of 4 × 10⁻¹¹. The other involved a DNA marker for NAT2 acetylation status, meaning the rate at which the NAT2 enzyme processes certain chemicals. Its P value was 4 × 10⁻¹¹.
At both the GSTM1 and NAT2 regions, the researchers found interactions with smoking: the genetic associations with bladder cancer risk varied with smoking. These findings concerned susceptibility, or the risk of developing the disease, and linked common DNA differences to that risk. The authors said the associations should give researchers new insights into how cancer develops.